CAS 2125968-05-8

Fórmula: C29H37FN6O4S

InChI: InChI=1S/C29H37FN6O4S/c1-21(2)35-10-8-34(9-11-35)20-22-4-5-25(26(30)16-22)27-17-23(6-7-31-27)33-41(37,38)28-18-24(19-32-29(28)39-3)36-12-14-40-15-13-36/h4-7,16-19,21H,8-15,20H2,1-3H3,(H,31,33)

Chave InChI: ODQVPYNCHSLNGV-UHFFFAOYSA-N

SMILES: CC(C)N1CCN(CC1)CC2=CC(=C(C=C2)C3=NC=CC(=C3)NS(=O)(=O)C4=C(N=CC(=C4)N5CCOCC5)OC)F

GSK251

CAS: 2125968-05-8

GSK251

Fórmula: C₂₉H₃₇FN₆O₄S

Pureza: 99.5%

Peso molecular: 584.71

Ref: 54-BUP01819

GSK251

CAS: 2125968-05-8

GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.

Fórmula: C₂₉H₃₇FN₆O₄S

Pureza: 99.8%

Cor e Forma: White Solid

Peso molecular: 584.705

Ref: TM-T39573

GSK251

CAS: 2125968-05-8

Ref: IN-DA023JLM

N-(2-(2-Fluoro-4-((4-isopropylpiperazin-1-yl)methyl)phenyl)pyridin-4-yl)-2-methoxy-5-morpholinopyridine-3-sulfonamide

CAS: 2125968-05-8

Fórmula: C₂₉H₃₇FN₆O₄S

Pureza: 99%

Peso molecular: 584.71

Ref: IN-DG01454713